Noncytotoxic polymyxin derivatives enhance antibiotic action against multidrug-resistant Gram-negative bacteria
Antimicrobial Agents and Chemotherapy · 05.11.2025 · 69 (11)
DOI: 10.1128/aac.00712-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.11.2025. Verfasst von Danyel Ramirez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial, Gram-Negative Bacteria, Polymyxins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSERC, UMGF.
Abstract (Originalsprache)
The widespread emergence of multidrug-resistant (MDR) Gram-negative bacteria prompted the reintroduction of polymyxins in the clinic despite their adverse effects. Ongoing research is primarily focused on the development of non-nephrotoxic and -neurotoxic polymyxins as not only standalone agents but also as potentiators that enhance the activity of a partner antibiotic. Safer derivatives of polymyxin B 3 , a minor component of polymyxin B, were synthesized and utilized as a potentiator of multiple antibiotics. Compound 1 , consisting of Dap residues, was nontoxic to kidney cells and is a promising outer membrane permeabilizer that synergized with six different classes of antibiotics against MDR Gram-negative bacteria. Compound 1 extended the activity spectrum of rifampicin, zoliflodacin, and pristinamycin by lowering the minimum inhibitory concentrations of these antibiotics below their interpretative susceptibility breakpoints in MDR Pseudomonas aeruginosa , Acinetobacter baumannii , Escherichia coli , Klebsiella pneumoniae , and Enterobacter cloacae . Notably, the novel combination of zoliflodacin, a first-in-class antibiotic in phase III trials for gonorrhea, and compound 1 exhibited potent bactericidal activity in MDR P. aeruginosa and A. baumannii .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
- Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada.
- Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
ORCID-Profile: Danyel Ramirez, Frank Schweizer
Förderung
- NSERC
- UMGF
Zitieren
APA
Ramirez, D., Ramirez, D. M., Arora, R., Arthur, G., & Schweizer, F. (2025). Noncytotoxic polymyxin derivatives enhance antibiotic action against multidrug-resistant Gram-negative bacteria. Antimicrobial Agents and Chemotherapy, 69(11). https://doi.org/10.1128/aac.00712-25
Vancouver
Ramirez D, Ramirez DM, Arora R, Arthur G, Schweizer F. Noncytotoxic polymyxin derivatives enhance antibiotic action against multidrug-resistant Gram-negative bacteria. Antimicrobial Agents and Chemotherapy. 2025;69(11). doi:10.1128/aac.00712-25
BibTeX
@article{Ramirez2025,
author = {Ramirez, Danyel and Ramirez, Danzel Marie and Arora, Rajat and Arthur, Gilbert and Schweizer, Frank},
title = {Noncytotoxic polymyxin derivatives enhance antibiotic action against multidrug-resistant Gram-negative bacteria},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
volume = {69},
number = {11},
doi = {10.1128/aac.00712-25}
}
EUVIMED